Publications
- Outcomes of Treatment With Infliximab for Ulcerative Colitis and Predictors of Sustained Clinical ResponsePublication without faculty affiliation
- Outcomes of Treatment With Infliximab for Ulcerative Colitis and Predictors of Sustained Clinical Response.Publication without faculty affiliation
- Predictors of sustained response to infliximab in patients with Crohn´s disease: a single cohort studyPublication without faculty affiliation
- Low serum deoxyribonuclease I activity is associated with antiTNF-alpha induced skin adverse events in patients with inflammatory bowel disease2012 | First Faculty of Medicine
- Bile Acid Malabsorption in Inflammatory Bowel Disease: Assessment by Serum Markers2011 | First Faculty of Medicine
- Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel Diseases2011 | First Faculty of Medicine
- Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: Calprotectin and IL-6 changes do not correspond to sRAGE changes2010 | First Faculty of Medicine
- Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort2010 | First Faculty of Medicine
- Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort2010 | Publication without faculty affiliation
- Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: Calprotectin and IL-6 changes do not correspond to sRAGE changes2010 | Publication without faculty affiliation
Loading network view...